Navigation Links
FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA
Date:4/30/2008

- New system addresses the needs of the medical community; builds on proven

efficacy and safety of TRELSTAR(R) -

CORONA, Calif., April 30 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has approved MIXJECT(TM), the new delivery system for TRELSTAR(R) (triptorelin pamoate for injectable suspension), a palliative treatment for advanced prostate cancer. MIXJECT(TM), developed and manufactured by Medimop Medical Projects Ltd. a subsidiary of West Pharmaceutical Services, Inc., combines the proven efficacy of TRELSTAR(R) DEPOT 3.75 mg and TRELSTAR(R) LA 11.25 mg with new features that make preparation, administration and disposal easier.

These new features include: a smaller 21-gauge needle for improved patient comfort; reconstitution without the use of a needle; and a shield covering the needle both before and after drug administration. The system is specifically designed to encourage compliance with OSHA (Occupational Safety and Health Administration) regulations within the medical community.

"At Watson, we understand what matters most for the physicians who prescribe our products and for the patients whose lives are impacted by them. Through these types of innovations, we are committed to developing effective, safe and convenient treatments that improve the lives of patients with urological conditions," said Edward Heimers, Jr., Executive Vice President and President of Watson's Brand Division. "The new MIXJECT(TM) drug delivery system was designed with a smaller needle size and updated features that promote OSHA compliance based on the needs and suggestions from our customers in c
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
3. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
4. NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
7. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
8. FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
9. FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
10. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
11. FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , NEW YORK, Dec. 1 ...rch report is available in its catalogue: ,, ...w.reportlinker.com/p0164494/Chromium---Global-Mark...m is primarily influenced by stainless steel, whil...arkets is also important for growth of chromium me...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 ...rch report is available in its catalogue: ,, E... Market dynamics and the changing healthcare and r...ker.com/p0165658/Emerging-Clinical-Trial-Locations...-healthcare-and-regulatory-environment.html ,,...
(Date:12/1/2009)..., , CAMBRIDGE, Mass., Dec. 1 /PRNews... biology industry and to promote its potential, a ...ormation of the Synthetic Biology Industry Associa...k. The goal of the association is to provide a for...cuss the new industry, address its opportunities a...
(Date:12/1/2009)..., , SHANGHAI, Dec. 1 /PRNewswire-Asia/...ry of ShangPharma, a leading China-based Contract ... a winner of the 2009 Deloitte,Technology Fast 50 ...ing high,tech companies in China. The award is a t...evenue growth from 2006 to 2008. , The re...
Breaking Biology Technology:Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3
...Metic Life Sciences Inc.,(TSX: PLI) ("ProMetic") t...02 compound in clinical trial in patients with che...ess of the European Hematology Association,held in... ProMetic,s Director R&D, Biology, presented data ...es hemoglobin level and red,blood cell count in ch...
...giotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX:...al device company, today announced the market laun... be available immediately for distribution,and sal...(TM), which is made from a rapidly resorbing,polym...osure applications,and indicated for soft tissue a...
...r, Inc. (NYSE: BEC ), a leading developer, manufa...tomate, and innovate complex biomedical tests,anno...events. Please mark,your calendars accordingly., ...31202/BECLOGO ), -- Q2 2008 Earnings Release sche..., 2008, Washington, DC - The American Association ...
Other Biology Technology:Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association 2Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association 3Angiotech announces market launch of Quill(TM) SRS MONODERM(TM) 2Angiotech announces market launch of Quill(TM) SRS MONODERM(TM) 3Angiotech announces market launch of Quill(TM) SRS MONODERM(TM) 4Upcoming Beckman Coulter Investor Events Second Half of 2008 2
(Date:12/1/2009)... , SUNNYVALE, Calif., Dec. 1 /PRNewswire/ ...he CUBE, Release 3.0 - a turnkey, portable, plug a...advertising, exhibits, entertainment and touring p...f dozens of patents in camera-enabled gesture reco...tation and entertainment systems. ,, Guaranteed...
(Date:12/1/2009)...UMBUS, Ohio Ohio State University cancer research...oth kills brain-tumor cells and blocks the growth ...ws that viruses designed to kill cancer cells onc...gressive brain tumors if they also carry a gene fo...The protein, called vasculostatin, is normally pro...
(Date:12/1/2009)...July the scientists, one from the United States, t...Brutus, the leader of his wolf pack, on remote Ell... Their goal to finally find out what these "North...in one of the harshest areas of the world., "We ... said David Mech, a renowned U.S. Geological Surve...
Breaking Biology News(10 mins):GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Tumor-attacking virus strikes with 'one-two punch' 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3StoredIQ Shares Expertise at IQPCs eDiscovery Pharma Biotech and Medical Device Conference 13978 1StoredIQ Shares Expertise at IQPCs eDiscovery Pharma Biotech and Medical Device Conference 13978 2U S Leadership in Medical Innovation Depends on Education and Immigration Policy Say Experts at Capitol Hill Briefing on Education 26 Immigration 3 56754 1U S Leadership in Medical Innovation Depends on Education and Immigration Policy Say Experts at Capitol Hill Briefing on Education 26 Immigration 3 56754 2U S Leadership in Medical Innovation Depends on Education and Immigration Policy Say Experts at Capitol Hill Briefing on Education 26 Immigration 3 56754 3U S Leadership in Medical Innovation Depends on Education and Immigration Policy Say Experts at Capitol Hill Briefing on Education 26 Immigration 3 56754 4Cantel Medical Corp to Present at the UBS Global Life Sciences Conference 56751 1
...hlid fish that evolved to lure female fish so that...uths. A study in the online open access journal BM... egg-like markings on the fins of cichlid fishes a...ings, which are central to the success of the fish...rger, Ingo Braasch and Axel Meyer reared 19 cichli...
...r to understanding why humans differ so greatly fr..., and fight off disease, despite having genes that...ch from the University of Torontos Centre for Cell...tial new explanations for these glaring difference... and chimpanzees, U of T Professor Benjamin Blenco...
...le Report for North America, released online this ...inds the continents carbon budget increasingly ove...n sources release nearly 2 billion tons of carbon ...oxide. Carbon sinks such as growing forests may ...inks may turn into new sources as climate changes....
Other Biology News:University of Toronto finds humans and chimps differ at level of gene splicing 2First-ever 'State of the Carbon Cycle Report' finds troubling imbalance 2
...e reagents required for a fast and convenient dete... in cell and tissue extracts and in purified micro...sted on samples prepared from mammalian tissues su...le from several species, as well as on lysates fro...
...vides the reagents to efficiently differentiate mo... By efficiently promoting myogenic differentiation...myogenesis, transcription factor regulation, and i...t therapy. By providing the means to obtain and ma...
...on Assay is an anchorage-independent growth assay ...nt assay for detecting malignant transformation of...arcinogens or carcinogen inhibitors) are cultured ...21-28 days. Following this incubation period, for...
Varian 2200 Ion Trap GC/MS from Varian, Inc.
Biology Products: